Clinical Study
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls
Table 3
Overview RNFLT between SD- and TD-OCT in MS and control groups, separated by quadrants.
| | SD-OCT μm mean (SD) | TD-OCT μm mean (SD) | | Control | MS | Control | MS |
| Average | 98.59 (6.79) | 88.80 (17.55) | 100.67 (8.96) | 90.9107 (18.26) | Superior | 121.27 (16.22) | 107.25 (26.95) | 117.48 (16.87) | 101.88 (27.04) | Temporal | 71.17 (10.88) | 65.02 (15.92) | 70.86 (12.88)* | 65.82 (17.57)* | Inferior | 127.16 (13.10) | 114.80 (21.64) | 133.23 (13.59) | 120.36 (27.08) | Nasal | 74.55 (11.21) | 68.07 (21.53) | 81.031 (15.75) | 72.20 (24.34) |
|
|
*All measures are significantly different between MS patients and control except for temporal quadrant measured by TD-OCT.
|